Pharma and healthcare: sector news on Sunday 15 November 2026
Average tone +7.3 (strongly positive) across 2 companies with relevant coverage, from 15 stories.
How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| AstraZeneca | +7.5 | 9 | Coverage leaned positive on US approvals for two treatments and progress toward EU clearance for a hypertension drug. |
| GSK | +7.0 | 6 | Coverage leaned positive, led by earnings call commentary pointing to strong growth, a Canadian approval for a hepatitis B therapy and a favourable European regulatory opinion on Bexsero and Talzenna. |
| Convatec | — | 0 | |
| Haleon | — | 0 | |
| Smith & Nephew | — | 0 |
Strongest stories in the sector
- +10.0 US regulator clears new treatment for a rare muscle condition.
- +10.0 US clearance widens use of Imfinzi in bladder cancer.
- +9.2 Novel hypertension drug advancing toward European regulatory clearance.
- +9.2 Earnings call coverage points to strong growth despite some pressures.</br>
- +8.3 European regulator backs Bexsero booster and wider Talzenna use.
- +8.3 Canadian approval of first hepatitis B functional-cure treatment, likely GSK's.
- +4.2 AZ named as a client moving to SAP cloud; mainly an SAP story.
- +4.2 AZ commits to a large cloud migration; focus is on SAP.
- −3.3 Job losses in the US, though part of a cost-saving programme.
- −2.5 Share-focused look at US sales reductions and cost drive.
- +2.5 AZ cloud deal mentioned, but story centres on SAP.
- +2.5 AZ cloud deal is a minor part of an SAP story.
Pharma and healthcare: every day · FTSE 100 overview for the day
Follow by email
A short, free morning email on how the news treated the Pharma and healthcare sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.